Enfermedades Sistémicas de Base Autoinmune

Molina-Collada, J; Monjo-Henry, I; Fernández-Fernández, E; Alvaro-Gracia, JM; De Miguel, E.

The OMERACT giant cell arteritis ultrasonography score: a potential predictive outcome for assessing the risk of relapse during follow-up

RHEUMATOLOGY. 2024; 64(3): 1448-1452 Nº de citas: 2 [doi:10.1093/rheumatology/keae260]

Garcia-Pompermayer, MR; Ayton, SG; Molina-Collada, J; Tamborrini, G; Sanchez, MED; Luna, KS; Elizondo, MAG.

The power of us: breaking barriers and bridging the gap of ultrasound in rheumatology to empower a new generation

CLINICAL RHEUMATOLOGY. 2024; 43(6): 2103-2116 Nº de citas: 1 [doi:10.1007/s10067-024-06973-w]

Herández-Cruz, B; Otero-Varela, L; Freire-González, M; Busquets-Pérez, N; González, AJG; Moreno-Ramos, M; Blanco-Madrigal, JM; Manrique-Arija, S; Perez-Pampin, E; Ruiz-Montesino, D; Sánchez-Alonso, F; Sanchez-Piedra, C; Castrejón, I.

Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry

ANNALS OF THE RHEUMATIC DISEASES. 2024; 83(9): 1189-1199 [doi:10.1136/ard-2023-225271]

García-Dorta, A; González-Dávila, E; Sánchez-Jareño, M; Cea-Calvo, L; Pombo-Suárez, M; Sánchez-Alonso, F; Castrejón, I; Díaz-González, F.

Early identification of golimumab-treated patients with higher likelihood of long-term retention

Frontiers in Immunology. 2024; 15: Nº de citas: 1 [doi:10.3389/fimmu.2024.1359571]

Izquierdo, MG; Blasco, JB; Ortega, SP; Salman-Monte, TC; Vela-Casasempere, P; Almaraz, ER; Calvo-Alen, J; Alvaro, JMAG; Ajo, MJB; Renau, RR; Galvez-Fernandez, M; Bahamontes-Rosa, N; Hernández, JSC; Marsiñach, CS.

Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study

LUPUS. 2024; 33(7): 663-674 Nº de citas: 3 [doi:10.1177/09612033241242886]

Rua-Figueroa, I; de Yébenes, MJG; Martinez-Barrio, J; Izquierdo, MG; Alén, J; Fernandez-Nebro, A; Menor-Almagro, R; Carmona, L; Segura, BT; Tomero, E; Freire-González, M; Sangüesa, C; Horcada, L; Blanco, R; Itzazelaia, EU; Narvaez, J; de Salazar, JCRG; Gómez-Sabater, S; Morales, CM; Andreu, JL; Segarra, VT; Aurrecoechea, E; Perez, A; Medina, JN; Salgado, E; Lozano-Rivas, N; Montilla, C; Ruiz-Lucea, E; Arevalo, M; Iñiguez, C; García-Villanueva, MJ; Exposito, L; Ibáñez-Barcelo, M; Bonilla, G; Carrión-Barberà, I; Erausquin, C; Gil, JJF; Pecondón, A; Toyos, FJ; Cobo, T; Muñoz-Jiménez, A; Oller, J; Nolla, JM; Pego-Reigosa, JM.

SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

LUPUS SCIENCE & MEDICINE. 2024; 11(1): Nº de citas: 2 [doi:10.1136/lupus-2023-001096]

Christiansen, SN; Rasmussen, SH; Pons, M; Michelsen, B; Glintborg, B; Gudbjornsson, B; Grondal, G; Vencovsky, J; Loft, AG; Rotar, Z; Pirkmajer, KP; Nissen, MJ; Baranova, J; Macfarlane, GJ; Jones, GT; Iannone, F; Caporali, R; Laas, K; Vorobjov, S; Di Giuseppe, D; Olofsson, T; Provan, SA; Fagerli, KM; Castrejon, I; Otero-Varela, L; van de Sande, M; van der Horst-bruinsma, I; Nordström, D; Kuusalo, L; Bernardes, M; Hetland, ML; Ostergaard, M; Ornbjerg, LM.

Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice

SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024; 65: Nº de citas: 4 [doi:10.1016/j.semarthrit.2024.152388]

Altabás-González, I; Pego-Reigosa, JM; Mouriño, C; Jiménez, N; Hernández-Martín, A; Casafont-Solé, I; Urguelles, JF; Román-Ivorra, JA; Navarro, MD; Galindo-Izquierdo, M; Salman-Monte, TC; Narváez, J; Vidal-Montal, P; García-Villanueva, MJ; Garrote-Corral, S; Blázquez-Cañamero, MA; Marras, C; Piqueras-García, M; Martínez-Barrio, J; Sánchez-Lucas, M; Cortés-Hernández, J; Penzo, E; Calvo-Alén, J; de Dios, JR; Rodríguez, B; Vasques-Rocha, M; Tomero, E; Menor-Almagro, R; Gandía, M; Gómez-Puerta, JA; Frade-Sosa, B; Ramos-Giráldez, C; Trapero-Pérez, C; Diez, E; Moriano, C; Muñoz-Jiménez, A; Rua-Figueroa, IJ.

Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients

RHEUMATOLOGY. 2024; 64(1): 276-282 Nº de citas: 3 [doi:10.1093/rheumatology/kead696]

Hellamand P; van de Sande MGH; Ørnbjerg LM; Klausch T; Eklund KK; Relas H; Santos MJ; Vieira-Sousa E; Loft AG; Glintborg B; Østergaard M; Lindström U; Wallman JK; Michelsen B; Fagerli KM; Castrejón I; Gudbjornsson B; Love TJ; Vencovský J; Nekvindová L; Rotar Ž; Tomšic M; Díaz-González F; Kenar G; Tugsal HY; Iannone F; Ramonda R; Codreanu C; Mogosan C; Nissen MJ; Möller B; Hetland ML; van der Horst-Bruinsma IE.

Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network.

ARTHRITIS & RHEUMATOLOGY. 2024; 76(4): 587-598 Nº de citas: 7 [doi:10.1002/art.42758]

Calvo-Gutiérrez, J; López-Medina, C; Otero-Varela, L; Escudero-Contreras, A; Ortega-Castro, R; Ladehesa-Pineda, L; Campos, C; Bernabeu-Gonzalvez, P; Pérez-Gómez, A; García-Dorta, A; Ruiz-Montesino, D; Pombo-Suarez, M; Ros-Vilamajo, I; Sánchez-Alonso, F; Castrejón, I.

Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry

ARTHRITIS RESEARCH & THERAPY. 2024; 26(1): Nº de citas: 2 [doi:10.1186/s13075-024-03287-9]

Rivera, J; Molina-Collada, J; Martinez-Barrio, J; Serrano-Benavente, B; Castrejon, I; Vallejo, MA; Alvaro-Gracia, JM.

Opioids and fibromyalgia: frequency of use and factors associated with increased consumption in patients remitted to a tertiary care center

BMC MUSCULOSKELETAL DISORDERS. 2024; 25(1): Nº de citas: 6 [doi:10.1186/s12891-024-07263-x]

Otín, T; Carmona, L; Rivera, J.

Patient-journey of fibromyalgia patients: A scoping review

Reumatologia Clinica. 2024; 20(2): 96-103 Nº de citas: 2 [doi:10.1016/j.reuma.2023.07.006]

Molina-Collada, J; Alonso, F; Otero, L; Bohórquez, C; Torné, CD; García, CP; Madrigal, JMB; Vela, P; Alvaro-Gracia, JM; Castrejón, I.

Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register

SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024; 64: 152341-152341 Nº de citas: 2 [doi:10.1016/j.semarthrit.2023.152341]

Molina-Collada, J; Domínguez-Alvaro, M; Melero-González, RB; Fernández-Fernández, E; Silva-Díaz, M; Valero, JA; González, I; Martín, JS; Narváez, J; Calvo, I; Mendizábal, J; Alcázar, LA; Loricera, J; Ruíz-Román, A; Moya, P; Cabañas, MT; Estrada, P; Prado-Galbarro, FJ; Castañeda, S; Blanco, R.

Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER Registry

RHEUMATOLOGY. 2024; 64(2): 697-703 Nº de citas: 5 [doi:10.1093/rheumatology/keae042]

Alten, R; Nieto-Gonzalez, JC; Jacques, P; Montecucco, C; Moots, R; Radner, H; Vonkeman, HE; Heidenreich, S; Whichello, C; Krucien, N; Van Beneden, K.

What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment

Rmd Open. 2024; 10(1): [doi:10.1136/rmdopen-2023-003311]

Hellamand, P; van de Sande, M; Ornbjerg, LM; Klausch, T; Nurmohamed, MT; van Vollenhoven, RF; Nordström, D; Hokkanen, AM; Santos, MJ; Vieira-Sousa, E; Loft, AG; Glintborg, B; Hetland, ML; Lindström, U; Wallman, JK; Michelsen, B; Kristianslund, EK; Ciurea, A; Nissen, MS; Codreanu, C; Mogosan, C; Macfarlane, GJ; Rotariu, O; Rotar, Z; Tomsic, M; Castrejon, I; Otero-Varela, L; Gudbjornsson, B; Geirsson, AJ; Vencovsky, J; Pavelka, K; Gulle, S; Zengin, B; Iannone, F; Foti, R; Ostergaard, M; van der Horst-Bruinsma, I.

Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: results from the EuroSpA Research Collaboration Network

Rmd Open. 2023; 9(4): Nº de citas: 1 [doi:10.1136/rmdopen-2023-003325]

Membrive-Jiménez, C; Sánchez-Piedra, C; Martínez-González, O; García-González, J; Expósito-Pérez, L; Bohórquez-Heras, C; Campos-Fernández, C; Sanchez-Alonso, F; Cáliz-Cáliz, R; Castrejón-Fernández, I.

Safety and effectiveness of bDMARDs during pregnancy in patients with rheumatic diseases: Real-world data from the BIOBADASER registry

Reumatologia Clinica. 2023; 19(9): 500-506 Nº de citas: 2 [doi:10.1016/j.reuma.2023.02.003]

Linde, L; Ornbjerg, LM; Rasmussen, SH; Love, TJ; Loft, AG; Závada, J; Vencovsky, J; Laas, K; Nordstrom, D; Sokka-Isler, T; Gudbjornsson, B; Gröndal, G; Iannone, F; Ramonda, R; Hellamand, P; Kristianslund, EK; Kvien, TK; Rodrigues, AM; Santos, MJ; Codreanu, C; Rotar, Z; Tomsic, M; Castrejon, I; Díaz-Gonzáles, F; Di Giuseppe, D; Ljung, L; Nissen, MJ; Ciurea, A; Macfarlane, GJ; Heddle, M; Glintborg, B; Ostergaard, M; Hetland, ML.

Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration

ARTHRITIS RESEARCH & THERAPY. 2023; 25(1): Nº de citas: 2 [doi:10.1186/s13075-023-03184-7]